Q3 2026 · 1 tracked holders Snapshot · 16 Nov 2026 Export CSV
Security file · CUSIP 868459108

Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. · held by 1 tracked manager in Q3 2026.

Tracked holders · Q3 2026
1
+0 vs Q2 2026
Aggregate reported value
$6.76M
sum of holders' reported positions
New holders this quarter
0
1 added · 0 trimmed
Holder return since filing
—
weighted by each holder's position share · since filing
Ownership · Q3 2026
ManagerWeight SharesΔ shares Entry Return ValueActivity
1 Third Avenue Managementfiled 13 Nov ET 1.13% 157K +2.9% — — $6.76M Added
Holder count
Q1 2023Q2 2023Q4 2024Q1 2025Q4 2025Q2 2026Q3 20261
Aggregate reported value
Q1 2023Q2 2023Q4 2024Q1 2025Q4 2025Q2 2026Q3 2026$9.42M
Quarterly aggregation
QuarterHoldersΔ holdersAggregate valueTotal shares
Q3 2026 1 +0 $6.76M 157K
Q2 2026 1 +0 $7.10M 153K
Q4 2025 1 +0 $9.42M 189K
Q1 2025 1 +0 $6.21M 189K
Q4 2024 1 +0 $6.85M 189K
Q2 2023 1 +0 $223K 7,409
Q1 2023 1 — $305K 8,406